Expression of cytolytic lymphocyte-associated antigens in pulmonary lymphomatoid granulomatosis

American Journal of Clinical Pathology

Volumn 118, Issue 3, 2002, Pages 391-398

  Morice, William G ^a   Kurtin, Paul J ^b   Myers, Jeffrey L ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Adult; Biology; Etiology; Immunophenotyping; Lung diseases; Lymphomatoid granulomatosis; Lymphoproliferative disorders; Pathology

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; CYTOLYTIC LYMPHOCYTE ASSOSCIATED ANTIGEN; GRANULE MEMBRANE PROTEIN 17; GRANZYME B; LYMPHOCYTE ANTIGEN; MEMBRANE PROTEIN; PARAFFIN; PEROXIDASE; UNCLASSIFIED DRUG; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN BARR VIRUS ENCODED RNA 2; EPSTEIN-BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 2; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; VIRUS RNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CYTOTOXICITY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LUNG BIOPSY; LUNG GRANULOMATOSIS; LYMPHOMATOID GRANULOMATOSIS; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; CYTOTOXIC T LYMPHOCYTE; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; IMMUNOLOGY; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; LUNG DISEASE; PATHOGENICITY; PATHOLOGY; SURVIVAL RATE; VIROLOGY; VIRUS INFECTION;

ANTIGENS, CD; ANTIGENS, SURFACE; B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LUNG DISEASES; LYMPHOMATOID GRANULOMATOSIS; RNA, VIRAL; SURVIVAL RATE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036715598     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/PMR7-7XLY-F10U-4V1Q     Document Type: Article

References (31)

1. Liebow AR, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol. 1972;3:457-558.
2. Guinee D Jr, Jaffe E, Kingma D, et al. Pulmonary lymphomatoid granulomatosis: evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol. 1994;18:753-764.
3. Myers JL, Kurtin PJ, Katzenstein AL, et al. Lymphomatoid granulomatosis: evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol. 1995;19:1300-1312.
4. Nicholson AG, Wotherspoon AC, Diss TC, et al. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Histopathology. 1996;29:317-324.
5. Yousem SA, Randhawa P, Locker J, et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol. 1989;20:361-369.
6. Swerdlow SH. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology. 1992;20:373-385.
7. Felgar RE, Steward KR, Cousar JB, et al. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower bcl-2 expression than diffuse large-B-cell lymphomas. Am J Pathol. 1998;153:1707-1715.
8. Kontani K, Sawai S, Hanaoka J, et al. Involvement of granzyme B and perform in suppressing nodal metastasis of cancer cells in breast and lung cancers. Eur J Surg Oncol. 2001;27:180-186.
9. ten Berge RL, Oudejans JJ, Dukers DF, et al. Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker. Leukemia. 2001;15:458-464.
10. Yakirevich E, Izhak OB, Rennert G, et al. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Mod Pathol. 1999;12:1050-1056.
11. Chan AC, Ho JW, Chiang AK, et al. Phenotypic and cytotoxic characteristics of peripheral T-cell and NK-cell lymphomas in relation to Epstein-Barr virus association. Histopathology. 1999;34:16-24.
12. Jaffe ES, Chan JK, Su U, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111.
13. Mason DY, Cordell J, Brown M, et al. Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol. 1989;42:1194-1200.
14. Morice WG, Leibson PJ, Tefferi A. Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis. Leuk Lymphoma. 2001;41:277-284.
15. Ng CS, Chan JK, Hui PK, et al. Application of a T cell receptor antibody beta F1 for immunophenotypic analysis of malignant lymphomas. Am J Pathol. 1988;132:365-371.
16. Medley QG, Kedersha N, O'Brien S, et al. Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci U S A. 1996;93:685-689.
17. Anderson P, Nagler-Anderson C, O'Brien C, et al. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol.1990;144:574-582.
18. Chinnaiyan AM, Hanna WL, Orth K, et al. Cytotoxic T-cell-derived granzyme B activates the apoptotic protease ICE-LAP3. Curr Biol. 1996;6:897-899.
19. Salcedo TW, Azzoni L, Wolf SF, et al. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol. 1993;151:2511-2520.
20. Chang KL, Chen YY, Shibata D, et al. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992;1:246-255.
21. Jaffe ES, Wilson WH. Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. Cancer Surv. 1997;30:233-248.
22. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of the Haematopoetic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
23. Bosshart H, Jarrett RF. Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's disease tumor cells. Blood. 1998;92:2252-2259.
24. Delabie J, Chan WC, Weisenburger DD, et al. The antigen-presenting cell function of Reed-Sternberg cells. Leuk Lymphoma. 1995;18:35-40.
25. Stopeck AT, Gessner A, Miller TP, et al. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Clin Cancer Res. 2000;6:3904-3909.
26. Felgar RE, Furth EE, Wasik MA, et al. Histiocytic necrotizing lymphadenitis (Kikuchi's disease): in situ end-labeling, immunohistochemical, and serologic evidence supporting cytotoxic lymphocyte-mediated apoptotic cell death. Mod Pathol. 1997;10:231-241.
27. Takakuwa T, Ohnuma S, Koike J, et al. Involvement of cell-mediated killing in apoptosis in histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease). Histopathology. 1996;28:41-48.
28. Gaillard F, Mechinaud-Lacroix F, Papin S, et al. Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Pathol. 1992;98:324-333.
29. Foss HD, Herbst H, Hummel M, et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood. 1994;83:707-712.
30. Haque AK, Myers JL, Hudnall SD, et al. Pulmonary lymphomatoid granulomatosis in acquired immunodeficiency syndrome: lesions with Epstein-Barr virus infection. Mod Pathol. 1998;11:347-356.
31. Wilson WH, Kingma DW, Raffeld M, et al. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood. 1996;87:4531-4537.